Skip to main content
NCBI home page
Cardiology and Therapy logoLink to Cardiology and Therapy
. 2025 May 24;14(3):491–492. doi: 10.1007/s40119-025-00417-5

Correction: Rationale and Design of ANTHOLOGY: An ATTR Amyloidosis Real-World Evidence Program Aiming to Address Gaps in Amyloidosis Care

Julian D Gillmore 1,✉, Katrin Hahn 2, J Gustav Smith 3, Isabel Conceição 4,5, Zhuang Tian 6, Martha Grogan 7, Christina Pao 8, Eric Wittbrodt 9, Krister Järbrink 10, Mia A Papas 11, Margot K Davis 12
PMCID: PMC12378813  PMID: 40411727

Correction: Cardiol Ther 10.1007/s40119-025-00402-y

In this article, the wrong figure appeared as Fig. 1. The incorrect and corrected versions of Fig. 1 are provided below:

Incorrect version:graphic file with name 40119_2025_417_Figa_HTML.jpg

Corrected version:

Fig. 1.

Fig. 1

Open in a new tab

OverTTuRe study design. ATTR amyloid transthyretin, ATTR-CM ATTR amyloidosis with cardiomyopathy, ATTR-PN ATTR amyloidosis with polyneuropathy. aIndex date is the earliest recorded ATTR amyloidosis diagnosis or treatment (if ATTR-specific treatment has occurred earlier than the earliest diagnosis, then the earliest treatment date will be the index date). bExit from database, death, or end of the database period

The original article has been corrected.

Articles from Cardiology and Therapy are provided here courtesy of Springer

RESOURCES